Analyst Charles Zhu from LifeSci Capital maintained a Buy rating on Mersana Therapeutics (MRSN – Research Report) and keeping the price target at $8.00. Discover outperforming stocks and invest ...

Freeways are by far the safest roads in Germany, "lighting has no influence on the number of accidents," said Kerstin Finis-Keck, Deputy Director of the North-East branch of Autobahn GmbH. An unlit ...

Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced the initiation of a Phase 2 ...

2025--(BUSINESS WIRE)--Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced the ...

About Autobahn Therapeutics Autobahn Therapeutics is a biotechnology company developing a portfolio of neuropsychiatric and neuroimmunologic clinical candidates leveraging its brain-targeting ...

About 300 young people engaged in multiple fights in a Wānaka park last night. Otago Lakes area police said they were called to Dinosaur Park about midnight after reports of fights. "At least three ...